Brazil today is a Disneyland for the pharmaceutical industry, says president of ANS

The president of the National Supplementary Health Agency (ANS), Paulo Rebello, highlights that the revenue that the pharmaceutical industry has obtained at the expense of other links in the health chain has been a problem for the sector, as well as the high accident rate and problems of costs that the sector was already having to deal with.

The president of ANS assesses that today, in Brazil, judicialization is intense and distinct compared to other countries, and in recent years we have observed changes that have increased pressure on the sector. He assesses that currently the country has become a very favorable environment for the pharmaceutical industry. “The country today is a Disneyland for the pharmaceutical industry, they earn a lot. If there is a prescription, the operator needs to supply the medicine, without the need for a prior assessment of its safety. This is a challenge that we need to address”, points out Rabello .

To the Broadcast (Grupo Estado’s real-time news system), he stated that the creation of Law 14,454 allows health plan beneficiaries to have access to medicines not incorporated by the regulatory agency, as long as there is scientific evidence of their effectiveness, creating a challenging scenario .